title: Con: Antifibrinolytics Should Not Be Used Routinely in Low-Risk Cardiac Surgery.
authors.affiliation: David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA. Electronic address: rharvey@mednet.ucla.edu.
authors.forename: Reed
authors.initials: R
authors.lastname: Harvey
authors.affiliation: David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
authors.forename: Ali
authors.initials: A
authors.lastname: Salehi
mesh_terms: D015119:Aminocaproic Acid / Q000009:adverse effects / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006348:Cardiac Surgical Procedures / Q000009:adverse effects* / Q000379:methods; D006801:Humans; D007431:Intraoperative Complications / Q000139:chemically induced* / Q000188:drug therapy / Q000209:etiology; D012307:Risk Factors; D014148:Tranexamic Acid / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000933:Antifibrinolytic Agents; D014148:Tranexamic Acid; D015119:Aminocaproic Acid
keywords: antifibrinolytics; cardiothoracic surgery; epsilon-aminocaproic acid; red blood cell transfusion; tranexamic acid